From 2018 we had worked with Pfizer to develop a vaccine for influenza. And we were already ready to start a clinical trial for that. But switching over to COVID, it was just a technical thing. And so it was already ready.


https://www.scientificamerican.com/article/an-mrna...[scientificamerican.com]

Katalin Karikó Quotes

From 2018 we had worked with Pfizer to develop a vaccine for influenza. And we were already ready to start a clinical trial for that. But switching...

From 2018 we had worked with Pfizer to develop a vaccine for influenza. And we were already ready to start a clinical trial for that. But switching...

From 2018 we had worked with Pfizer to develop a vaccine for influenza. And we were already ready to start a clinical trial for that. But switching...

From 2018 we had worked with Pfizer to develop a vaccine for influenza. And we were already ready to start a clinical trial for that. But switching...